The impact of EPA and DHA on blood lipids and lipoprotein metabolism: influence of apoE genotype.
Fish and fish oil-rich sources of long-chain n-3 fatty acids have been shown to be cardio-protective, through a multitude of different pathways including effects on arrhythmias, endothelial function, inflammation and thrombosis, as well as modulation of both the fasting and postprandial blood lipid profile. To date the majority of studies have examined the impact of EPA and DHA fed simultaneously as fish or fish oil supplements. However, a number of recent studies have compared the relative biopotency of EPA v. DHA in relation to their effect on blood lipid levels. Although many beneficial effects of fish oils have been demonstrated, concern exists about the potential deleterious impact of EPA and DHA on LDL-cholesterol, with a highly-heterogenous response of this lipid fraction reported in the literature. Recent evidence suggests that apoE genotype may be in part responsible. In the present review the impact of EPA and DHA on cardiovascular risk and the blood lipoprotein profile will be considered, with a focus on the apoE gene locus as a possible determinant of lipid responsiveness to fish oil intervention.
Anil
Eliz
E
Hugh Sinclair Unit of Human Nutrition, Department of Food Biosciences, PO Box 226, University of Reading, Whiteknights, Reading RG6 6AP, UK. e.anil@reading.ac.uk
D001057:Apolipoproteins E / Q000235:genetics*; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000008:administration & dosage* / Q000378:metabolism; D004537:Eicosanoic Acids / Q000008:administration & dosage* / Q000378:metabolism; D005395:Fish Oils; D005838:Genotype; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects*; D008055:Lipids / Q000097:blood*; D014280:Triglycerides / Q000097:blood
D001057:Apolipoproteins E; D004537:Eicosanoic Acids; D005395:Fish Oils; D008055:Lipids; D014280:Triglycerides; D004281:Docosahexaenoic Acids